XSHG600873
Market cap3.73bUSD
Jan 09, Last price
9.58CNY
1D
-1.34%
1Q
-5.34%
Jan 2017
46.93%
Name
MeiHua Holdings Group Co Ltd
Chart & Performance
Profile
MeiHua Holdings Group Co.,Ltd provides amino acid nutrition and health solutions. Its products include food additives, including sodium glutamate, natamycin, disodium 5'-ribonucleotide, disodium inosinate, xanthan gum, pullulan, and trehalose; condiments, such as monosodium glutamate (MSG); amino acid for feed comprising valine, L-lysine sulphate and HCL, L-threonine, L-tryptophane, corn gluten meal for feedstuffs, corn husk powder, corn fiber feed, and boutique MSG residue. The company also provides pharmaceutical amino acids consisting of L-glutamine, L-leucine, L-isoleucine, L-valine, BCAA, L-proline, inosine, vernine, and adenosine; colloids; enteric, cellulose, gelatin, and pullulan capsules; and fertilizers, which include soil conditioners. MeiHua Holdings Group Co.,Ltd was founded in 2002 and is headquartered in Langfang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 27,760,612 -0.63% | 27,937,153 22.33% | |||||||
Cost of revenue | 23,161,721 | 21,790,667 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 4,598,891 | 6,146,486 | |||||||
NOPBT Margin | 16.57% | 22.00% | |||||||
Operating Taxes | 542,186 | 746,483 | |||||||
Tax Rate | 11.79% | 12.14% | |||||||
NOPAT | 4,056,705 | 5,400,003 | |||||||
Net income | 3,180,950 -27.81% | 4,406,242 83.42% | |||||||
Dividends | (1,177,370) | (1,216,830) | |||||||
Dividend yield | 4.11% | 3.88% | |||||||
Proceeds from repurchase of equity | (896,190) | ||||||||
BB yield | 3.13% | ||||||||
Debt | |||||||||
Debt current | 1,543,869 | 1,335,928 | |||||||
Long-term debt | 2,005,144 | 3,686,049 | |||||||
Deferred revenue | 384,988 | 429,899 | |||||||
Other long-term liabilities | 441,377 | 10,500 | |||||||
Net debt | (2,420,722) | (596,483) | |||||||
Cash flow | |||||||||
Cash from operating activities | 5,228,937 | 5,654,954 | |||||||
CAPEX | (1,333,258) | ||||||||
Cash from investing activities | (1,540,361) | ||||||||
Cash from financing activities | (3,140,355) | ||||||||
FCF | 4,193,038 | 4,940,149 | |||||||
Balance | |||||||||
Cash | 5,241,073 | 4,509,225 | |||||||
Long term investments | 728,661 | 1,109,236 | |||||||
Excess cash | 4,581,704 | 4,221,603 | |||||||
Stockholders' equity | 13,130,307 | 11,677,690 | |||||||
Invested Capital | 13,569,111 | 14,382,219 | |||||||
ROIC | 29.03% | 38.79% | |||||||
ROCE | 25.31% | 32.72% | |||||||
EV | |||||||||
Common stock shares outstanding | 3,000,896 | 3,081,288 | |||||||
Price | 9.55 -6.19% | 10.18 32.72% | |||||||
Market cap | 28,658,556 -8.64% | 31,367,513 32.79% | |||||||
EV | 26,237,835 | 30,771,030 | |||||||
EBITDA | 5,977,414 | 7,529,947 | |||||||
EV/EBITDA | 4.39 | 4.09 | |||||||
Interest | 126,554 | 149,374 | |||||||
Interest/NOPBT | 2.75% | 2.43% |